An approach to quantitative two-component analysis of a mixture containing hydrochlorothiazide and spironolactone in tablets by one-dimensional continuous Daubechies and biorthogonal wavelet analysis of UV-spectra

被引:52
作者
Dinç, E
Baleanu, D
Üstündag, Ö
机构
[1] Ankara Univ, Fac Pharm, Dept Analyt Chem, TR-06100 Ankara, Turkey
[2] Univ Cankaya, Fac Arts & Sci, Dept Math & Comp Sci, Ankara, Turkey
[3] Natl Inst Laser Plasma & Radiat Phys, Inst Space Sci, Magurele, Romania
关键词
Daubechies and biorthogonal one-dimensional continuous wavelets; quantitative resolution; zero-crossing technique; hydrochlorothiazide and spironolactone; UV-visible spectrophotometry;
D O I
10.1081/SL-120024583
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
In this study a new method of quantitative two-component analysis of a mixture of hydrochlorothiazide (HCT) and spironolactone (SP) in the presence of strongly overlapping signals was achieved by using one-dimensional continuous wavelet analysis. This new method was built on the simultaneous use of both continuous wavelet transform and the zero crossing technique for the quantitative resolution of this binary mixture. A series of solutions, in the concentration range of 2-22 mg/ml for both compounds, in methanol and 0.2 M sodium acetate buffer, pH = 5 (20:80), were considered. The absorption spectra of the standard solutions were recorded in the wavelength range of 215-330 nm. To apply our methods we selected 400 points from the absorption spectra and we subjected the corresponding signal to Daubechies2 (DAUB2) and Biorthogonal1.5 (BIOR1.5) one-dimensional wavelet transform. In the transformed signals, the amplitude of HCT was measured at the position of a zero crossing point of SP and vice versa. Thus simple linear regression analysis can be applied to establish calibrations for both components. These calibrations were validated with synthetic mixtures of HCT and SP. MATLAB 6.5 software was used for one-dimensional wavelet analysis, and the basic concepts about wavelet method are briefly explained. The method developed in this paper is rapid, easy to apply, inexpensive and it is suitable for analysis of the overlapping signals of compounds in their mixtures without any chemical pre-treatment.
引用
收藏
页码:341 / 355
页数:15
相关论文
共 28 条
[1]  
ABDALLE A, 1999, ELECTROCHIM ACTA, V44, P4805
[2]   An introduction to wavelet transforms for chemometricians: A time-frequency approach [J].
Alsberg, BK ;
Woodward, AM ;
Kell, DB .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1997, 37 (02) :215-239
[3]   HPLC-PHOTOLYSIS ELECTROCHEMICAL DETECTION IN PHARMACEUTICAL ANALYSIS - APPLICATION TO THE DETERMINATION OF SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE IN TABLETS [J].
BACHMAN, WJ ;
STEWART, JT .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1990, 28 (03) :123-128
[4]   Application of wavelet transforms to experimental spectra: Smoothing, denoising, and data set compression [J].
Barclay, VJ ;
Bonner, RF ;
Hamilton, IP .
ANALYTICAL CHEMISTRY, 1997, 69 (01) :78-90
[5]   AN INTRODUCTION TO MULTIVARIATE CALIBRATION AND ANALYSIS [J].
BEEBE, KR ;
KOWALSKI, BR .
ANALYTICAL CHEMISTRY, 1987, 59 (17) :A1007-+
[6]   WAVELET TRANSFORM FOR THE EVALUATION OF PEAK INTENSITIES IN FLOW-INJECTION ANALYSIS [J].
BOS, M ;
HOOGENDAM, E .
ANALYTICA CHIMICA ACTA, 1992, 267 (01) :73-80
[7]  
Daubechies I., 1992, 10 LECT WAVELETS
[8]   The spectrophotometric multicomponent analysis of a ternary mixture of ascorbic acid, acetylsalicylic acid and paracetamol by the double divisor-ratio spectra derivative and ratio spectra-zero crossing methods [J].
Dinç, E .
TALANTA, 1999, 48 (05) :1145-1157
[9]   A zero-crossing technique for the multidetermination of thiamine HCl and pyridoxine HCl in their mixture by using one-dimensional wavelet transform [J].
Dinç, E ;
Baleanu, D .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (05) :969-978
[10]   Two new spectrophotometric approaches to the multicomponent analysis of the acetaminophen and caffeine in tablets by classical least-squares and principal component regression techniques [J].
Dinç, E ;
Baleanu, D .
FARMACO, 2002, 57 (01) :33-37